Ameritas Investment Partners’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Ameritas Investment Partners’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,248	Closed	-$18.6K	–	3263
2024 Q1	$18.6K	Hold	7,248	–	–	﹤0.01%	2589
2023 Q4	$14.8K	Hold	7,248	–	–	﹤0.01%	2716
2023 Q3	$12.5K	Hold	7,248	–	–	﹤0.01%	2734
2023 Q2	$14.1K	Buy	+7,248	New	+$17K	﹤0.01%	2749
2022 Q2	–	Sell	-3,302	Closed	-$14K	–	3277
2022 Q1	$14K	Hold	3,302	–	–	﹤0.01%	2697
2021 Q4	$42K	Buy	3,302 +756	+30%	+$8.37K	﹤0.01%	2245
2021 Q3	$27K	Hold	2,546	–	–	﹤0.01%	2544
2021 Q2	$23K	Hold	2,546	–	–	﹤0.01%	2674
2021 Q1	$24K	Buy	2,546 +370	+17%	+$5.1K	﹤0.01%	2496
2020 Q4	$9K	Hold	2,176	–	–	﹤0.01%	2851
2020 Q3	$6K	Hold	2,176	–	–	﹤0.01%	2943
2020 Q2	$14K	Hold	2,176	–	–	﹤0.01%	2554
2020 Q1	$13K	Hold	2,176	–	–	﹤0.01%	2412
2019 Q4	$20K	Hold	2,176	–	–	﹤0.01%	2417
2019 Q3	$19K	Hold	2,176	–	–	﹤0.01%	2430
2019 Q2	$24K	Buy	2,176 +1,606	+282%	+$18.4K	﹤0.01%	2352
2019 Q1	$8K	Hold	570	–	–	﹤0.01%	2777
2018 Q4	$9K	Buy	+570	New	+$10.9K	﹤0.01%	2722

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's GRTS Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 7,248 shares — an estimated $18.6K sold.

Ameritas Investment Partners first reported a position in GRTS in Q4 2018 and held it in 18 quarters. The position peaked at $42K in Q4 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

Ameritas Investment Partners reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Ameritas Investment Partners sold 7,248 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $18.6K.
Ameritas Investment Partners first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 18 quarters.
Ameritas Investment Partners's Gritstone bio, Inc. Common Stock position peaked at $42K in Q4 2021.
79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.